DekaBank Deutsche Girozentrale
BankPosition in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1456228
FRANKFURT, 2M
Position in ALNY
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$37,452,167
-$7,559,029 QoQ
Shares Held
113,193
0.0% QoQ
Ownership
0.085%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DekaBank Deutsche Girozentrale holds $665,183,872 across 48 Biotechnology names. ALNY ranks #4 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
506,457 | $226,153,308 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
211,207 | $163,186,975 | |
| 3 | BNTX |
BioNTech SE
|
481,397 | $42,786,564 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
113,193 | $37,452,167 | |
| 5 | RPRX |
Royalty Pharma plc
|
746,287 | $35,799,386 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
115,130 | $21,765,325 | |
| 7 | EXEL |
Exelixis, Inc.
|
429,690 | $18,429,403 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
280,330 | $15,835,841 |
All Filings in ALNY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $37,452,167 | 113,193 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $45,011,196 | 113,193 | Shares | Defined | 2026-01-28 | |
| 2025-09-30 | $51,616,008 | 113,193 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $36,911,105 | 113,193 | Shares | Defined | 2025-07-30 | |
| 2025-03-31 | $30,523,600 | 113,042 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $26,635,444 | 113,193 | Shares | Defined | 2025-01-29 | |
| 2024-09-30 | $31,131,470 | 113,193 | Shares | Defined | 2024-10-24 | |
| 2024-06-30 | $27,571,509 | 113,463 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $16,894,126 | 113,042 | Shares | Defined | 2024-06-04 | |
| 2023-12-31 | $26,392,567 | 137,885 | Shares | Defined | 2024-01-24 | |
| 2023-09-30 | $25,343,009 | 143,100 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $30,475,682 | 160,449 | Shares | Defined | 2023-07-25 | |
| 2023-03-31 | $24,848,694 | 124,045 | Shares | Defined | 2023-04-24 | |
| 2022-12-31 | $21,472,390 | 90,353 | Shares | Defined | 2023-02-01 | |
| 2022-09-30 | $17,692,342 | 88,391 | Shares | Defined | 2022-11-02 | |
| 2022-06-30 | $10,149,263 | 69,587 | Shares | Defined | 2022-08-03 | |
| 2022-03-31 | $9,334,961 | 57,168 | Shares | Defined | 2022-04-28 | |
| 2021-12-31 | $9,543,792 | 56,279 | Shares | Defined | 2022-02-02 | |
| 2021-09-30 | $8,389,961 | 44,436 | Shares | Defined | 2021-10-22 | |
| 2021-06-30 | $12,475,146 | 73,591 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $10,404,996 | 73,695 | Shares | Defined | 2021-04-28 | |
| 2020-12-31 | $9,312,088 | 71,648 | Shares | Defined | 2021-03-12 | |
| 2020-09-30 | $11,966,572 | 82,188 | Shares | Defined | 2020-10-29 | |
| 2020-06-30 | $1,144,001 | 7,724 | Shares | Defined | 2020-08-04 | |
| 2020-03-31 | $657,345 | 6,039 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||